Antibodies to Epstein-Barr virus in patients with Hodgkin's disease and leukemia.
Sera from 67 Hodgkin's disease patients, 71 leukemia patients, and 186 healthy subjects were tested for antibodies to Epstein-Barr (EB) viral antigens by immunofluorescence methods. In both disease categories, in particular Hodgkin's disease patients, levels of antibodies to the viral capsid antigen (EBV-VCA) and MGT were higher than in the healthy controls. Significantly higher titers were found in Jewish patients of Asian-African origin, as compared to Jews of European origin, with Arab patients as intermediates. The effect of ethnic origin was independant of age and histopathologic type. Sex had no effect on titer. Inconsistent differences in titer were found between age groups in the various ethnic-histopathologic type groups. Some of the leukemia patients had no detectable antibodies to EBV, while all Hodgkin's disease patients showed previous contact with EB virus. Antibodies to the early antigen (EBV-EA) were found in 27% of Hodgkin's and 37% of leukemia patients, and in none of the healthy controls tested.
D000293:Adolescent; D000349:Africa / Q000208:ethnology; D000367:Age Factors; D000914:Antibodies, Viral; D001208:Asia / Q000208:ethnology; D002648:Child; D002675:Child, Preschool; D005006:Ethnicity; D005060:Europe / Q000208:ethnology; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006689:Hodgkin Disease / Q000276:immunology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007557:Israel; D007585:Jews; D007938:Leukemia / Q000276:immunology*; D008297:Male; D012737:Sex Factors
D000914:Antibodies, Viral